Not really. Ibuprofen has been in use for a very long time, has well known and studied side-effects, and is readily available over the counter in generic form. There is no big lobby interest for Ibuprofin at this time, so the financial incentives there are not suspect.
On the other hand, any time I see a pharmaceutical ad for some new wonder drug, my incientive-caused-bias hackles are immediately raised.